Approach to Neonates and Young Infants with Fever without a Source Who Are at Risk for Severe Bacterial Infection
暂无分享,去创建一个
A. Argentiero | A. Mencacci | S. Esposito | N. Principi | V. E. Rinaldi | R. d’Alonzo | E. Farinelli | M. Cofini
[1] O. Ramilo,et al. Accuracy of the Urinalysis for Urinary Tract Infections in Febrile Infants 60 Days and Younger , 2018, Pediatrics.
[2] A. Berger,et al. Diagnostic accuracy of the ROCHE Septifast PCR system for the rapid detection of blood pathogens in neonatal sepsis—A prospective clinical trial , 2017, PloS one.
[3] S. Brkić,et al. Use of presepsin and procalcitonin for prediction of SeptiFast results in critically ill patients☆ , 2017, Journal of critical care.
[4] F. Balamuth,et al. Lumbar Puncture for All Febrile Infants 29-56 Days Old: A Retrospective Cohort Reassessment Study. , 2017, The Journal of pediatrics.
[5] A. Saitoh,et al. Human parechovirus type 3 infection: An emerging infection in neonates and young infants. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[6] A. van der Ende,et al. Listeria monocytogenes meningitis in the Netherlands, 1985–2014: A nationwide surveillance study , 2017, The Journal of infection.
[7] Thomas A. Hooven,et al. Pneumonia , 2017, Seminars in Fetal and Neonatal Medicine.
[8] R. McCulloh,et al. Facing the ongoing challenge of the febrile young infant , 2017, Critical Care.
[9] P. Montaldo,et al. Presepsin for the detection of early-onset sepsis in preterm newborns , 2017, Pediatric Research.
[10] S. Chawla,et al. Enhanced Identification of Group B Streptococcus and Escherichia Coli in Young Infants with Meningitis Using the Biofire Filmarray Meningitis/Encephalitis Panel , 2017, The Pediatric infectious disease journal.
[11] M. Monuteaux,et al. Urine Concentration and Pyuria for Identifying UTI in Infants , 2016, Pediatrics.
[12] J. R. Contreras,et al. Lack of Accuracy of Biomarkers and Physical Examination to Detect Bacterial Infection in Febrile Infants , 2016, Pediatric emergency care.
[13] F. Strle,et al. Narrowing of the Diagnostic Gap of Acute Gastroenteritis in Children 0–6 Years of Age Using a Combination of Classical and Molecular Techniques, Delivers Challenges in Syndromic Approach Diagnostics , 2016, The Pediatric infectious disease journal.
[14] O. Ramilo,et al. Association of RNA Biosignatures With Bacterial Infections in Febrile Infants Aged 60 Days or Younger. , 2016, JAMA.
[15] A. Gervaix,et al. Validation of the “Step-by-Step” Approach in the Management of Young Febrile Infants , 2016, Pediatrics.
[16] A. Mencacci,et al. Diagnostic accuracy of presepsin (sCD14-ST) and procalcitonin for prediction of bacteraemia and bacterial DNAaemia in patients with suspected sepsis. , 2016, Journal of medical microbiology.
[17] R. Jhaveri,et al. Evaluation and Management of Febrile Children: A Review. , 2016, JAMA pediatrics.
[18] S. Y. Kim,et al. Can absence of pyuria exclude urinary tract infection in febrile infants? About 2011 AAP guidelines on UTI , 2016, Pediatrics international : official journal of the Japan Pediatric Society.
[19] J. Vila,et al. Development of a new protocol for rapid bacterial identification and susceptibility testing directly from urine samples. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[20] V. Cheng,et al. Clinical Evaluation of the New High-Throughput Luminex NxTAG Respiratory Pathogen Panel Assay for Multiplex Respiratory Pathogen Detection , 2016, Journal of Clinical Microbiology.
[21] Kyrie L Shomaker,et al. A Meta-analysis of the Rates of Listeria monocytogenes and Enterococcus in Febrile Infants. , 2016, Hospital pediatrics.
[22] R. Jhaveri,et al. Reductions in neonatal listeriosis: "Collateral benefit" of Group B streptococcal prophylaxis? , 2016, The Journal of infection.
[23] F. Mosca,et al. Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates , 2015, PloS one.
[24] Joel S. Tieder,et al. Association between Clinical Outcomes and Hospital Guidelines for Cerebrospinal Fluid Testing in Febrile Infants Aged 29-56 Days. , 2015, The Journal of pediatrics.
[25] H. Wong,et al. Interleukin-27: a novel biomarker in predicting bacterial infection among the critically ill , 2015, Critical Care.
[26] S. Esposito,et al. Direct and indirect effects of the 13-valent pneumococcal conjugate vaccine administered to infants and young children. , 2015, Future microbiology.
[27] S. Mintegi,et al. A Prospective Multicenter Study of Leukopenia in Infants Younger Than Ninety Days With Fever Without Source , 2015, The Pediatric infectious disease journal.
[28] J. Lohr,et al. Pediatric Fever of Unknown Origin. , 2015, Pediatrics in review.
[29] D. Kimberlin,et al. Neonatal Herpes Simplex Virus Infection. , 2015, Infectious disease clinics of North America.
[30] Samir S. Shah,et al. Association of clinical practice guidelines with emergency department management of febrile infants ≤56 days of age. , 2015, Journal of hospital medicine.
[31] C. Asche,et al. Epidemiology of Bacteremia in Previously Healthy Febrile Infants: A Follow-up Study. , 2015, Hospital pediatrics.
[32] M. Blennow,et al. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference , 2015, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[33] S. Esposito,et al. Prospective evaluation of rhinovirus infection in healthy young children. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[34] E. Burdino,et al. Etiological diagnosis of bloodstream infections through a multiplex real-time polymerase chain reaction test in pediatric patients: a case series from a tertiary Italian hospital , 2015, Infectious diseases.
[35] A. Kimia,et al. The effect of traumatic lumbar puncture on hospitalization rate for febrile infants 28 to 60 days of age. , 2015, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[36] C. Dani,et al. Presepsin for the Detection of Late-Onset Sepsis in Preterm Newborns , 2015, Pediatrics.
[37] M. Loeffelholz,et al. Duration of Rhinovirus Shedding in the Upper Respiratory Tract in the First Year of Life , 2014, Pediatrics.
[38] S. Aronoff,et al. Use of serum procalcitonin in evaluation of febrile infants: a meta-analysis of 2317 patients. , 2014, The Journal of emergency medicine.
[39] Samir S. Shah,et al. Variation in Care of the Febrile Young Infant <90 Days in US Pediatric Emergency Departments , 2014, Pediatrics.
[40] H. Wong,et al. Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment , 2014, Expert review of clinical immunology.
[41] A. Ohlsson,et al. Intrapartum antibiotics for known maternal Group B streptococcal colonization. , 2014, The Cochrane database of systematic reviews.
[42] A. Herz,et al. The Changing Epidemiology of Serious Bacterial Infections in Young Infants , 2014, The Pediatric infectious disease journal.
[43] J. Craig,et al. Parental perspectives on evaluation and management of fever in young infants: an interview study , 2014, Archives of Disease in Childhood.
[44] L. Coin,et al. Diagnosis of childhood tuberculosis and host RNA expression in Africa. , 2014, The New England journal of medicine.
[45] M. Waseem,et al. Can a Simple Urinalysis Predict the Causative Agent and the Antibiotic Sensitivities? , 2014, Pediatric emergency care.
[46] S. Reif,et al. Diagnostic markers of serious bacterial infections in febrile infants younger than 90 days old , 2014, Pediatrics international : official journal of the Japan Pediatric Society.
[47] E. Alpern,et al. Management of Febrile Neonates in US Pediatric Emergency Departments , 2014, Pediatrics.
[48] Michael Levin,et al. Detection of Tuberculosis in HIV-Infected and -Uninfected African Adults Using Whole Blood RNA Expression Signatures: A Case-Control Study , 2013, PLoS medicine.
[49] G. Mengozzi,et al. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study , 2013, Critical Care.
[50] Colin G Fink,et al. Transcriptomic Profiling in Childhood H1N1/09 Influenza Reveals Reduced Expression of Protein Synthesis Genes , 2013, The Journal of infectious diseases.
[51] S. Crosby,et al. Gene expression profiles in febrile children with defined viral and bacterial infection , 2013, Proceedings of the National Academy of Sciences.
[52] S. Mintegi,et al. Accuracy of a sequential approach to identify young febrile infants at low risk for invasive bacterial infection , 2013, Emergency Medicine Journal.
[53] A. Gervaix,et al. Association of Procalcitonin With Acute Pyelonephritis and Renal Scars in Pediatric UTI , 2013, Pediatrics.
[54] S. Mintegi,et al. Diagnostic Performance of the Lab-score in Predicting Severe and Invasive Bacterial Infections in Well-appearing Young Febrile Infants , 2012, The Pediatric infectious disease journal.
[55] S. Mintegi,et al. Diagnostic Value of Procalcitonin in Well-Appearing Young Febrile Infants , 2012, Pediatrics.
[56] H. Wong,et al. Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children , 2012, Critical Care.
[57] Lucy Savitz,et al. Costs and Infant Outcomes After Implementation of a Care Process Model for Febrile Infants , 2012, Pediatrics.
[58] Virginia Pascual,et al. Host Immune Transcriptional Profiles Reflect the Variability in Clinical Disease Manifestations in Patients with Staphylococcus aureus Infections , 2012, PloS one.
[59] A. Tsertsvadze,et al. Diagnosis and management of febrile infants (0-3 months). , 2012, Evidence report/technology assessment.
[60] S. Ralston,et al. Occult serious bacterial infection in infants younger than 60 to 90 days with bronchiolitis: a systematic review. , 2011, Archives of pediatrics & adolescent medicine.
[61] L. Putignani,et al. Multiplex PCR Allows Rapid and Accurate Diagnosis of Bloodstream Infections in Newborns and Children with Suspected Sepsis , 2011, Journal of Clinical Microbiology.
[62] A. Schuchat,et al. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[63] R. Jhaveri,et al. Changing Epidemiology of Serious Bacterial Infections in Febrile Infants without Localizing Signs , 2010, PloS one.
[64] S. Schrag,et al. Group B streptococcal disease in infants: progress in prevention and continued challenges. , 2010, Clinics in perinatology.
[65] A. Gervaix,et al. Validation of a laboratory risk index score for the identification of severe bacterial infection in children with fever without source , 2010, Archives of Disease in Childhood.
[66] L. Carin,et al. Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. , 2009, Cell host & microbe.
[67] P. Dayan,et al. Influenza Virus Infection and the Risk of Serious Bacterial Infections in Young Febrile Infants , 2009, Pediatrics.
[68] Virginia Pascual,et al. Enhanced Monocyte Response and Decreased Central Memory T Cells in Children with Invasive Staphylococcus aureus Infections , 2009, PloS one.
[69] A. Gervaix,et al. The Search for Adenovirus 14 in Children in Houston, Texas , 2008, The Pediatric infectious disease journal.
[70] M. Plebani,et al. Procalcitonin and C-Reactive Protein as Diagnostic Markers of Severe Bacterial Infections in Febrile Infants and Children in the Emergency Department , 2007, The Pediatric infectious disease journal.
[71] J. Banchereau,et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. , 2007, Blood.
[72] P. Lebon,et al. Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis. , 2006, The Journal of pediatrics.
[73] V. Fowler,et al. Neonatal Meningitis: What Is the Correlation Among Cerebrospinal Fluid Cultures, Blood Cultures, and Cerebrospinal Fluid Parameters? , 2006, Pediatrics.
[74] A. Spitzer,et al. Empiric Use of Ampicillin and Cefotaxime, Compared With Ampicillin and Gentamicin, for Neonates at Risk for Sepsis Is Associated With an Increased Risk of Neonatal Death , 2006, Pediatrics.
[75] G. Garra,et al. Reappraisal of criteria used to predict serious bacterial illness in febrile infants less than 8 weeks of age. , 2005, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[76] Nathan Kuppermann,et al. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. , 2004, Pediatrics.
[77] C. Byington,et al. Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections. , 2004, Pediatrics.
[78] T. Newman,et al. Management and outcomes of care of fever in early infancy. , 2004, JAMA.
[79] L. Baraff. Editorial: Clinical policy for children younger than three years presenting to the emergency department with fever. , 2003, Annals of emergency medicine.
[80] C. Cubells,et al. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker , 2003 .
[81] Tiffany S. Glasgow,et al. Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens. , 2003, Pediatrics.
[82] D. Relman. New technologies, human-microbe interactions, and the search for previously unrecognized pathogens. , 2002, The Journal of infectious diseases.
[83] J. Coste,et al. Procalcitonin in children admitted to hospital with community acquired pneumonia , 2001, Archives of disease in childhood.
[84] S. Suter,et al. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs , 2001, European Journal of Pediatrics.
[85] R. Bolte,et al. Applying Outpatient Protocols in Febrile Infants 1-28 Days of Age: Can the Threshold Be Lowered? , 2000, Clinical pediatrics.
[86] M. Baker,et al. Evaluation and management of infants with fever. , 1999, Pediatric clinics of North America.
[87] J. Coste,et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. , 1999, The Pediatric infectious disease journal.
[88] L. Bell,et al. Unpredictability of serious bacterial illness in febrile infants from birth to 1 month of age. , 1999, Archives of pediatrics & adolescent medicine.
[89] J. Avner,et al. The efficacy of routine outpatient management without antibiotics of fever in selected infants. , 1999, Pediatrics.
[90] R. Evans. Complications of lumbar puncture. , 1998, Neurologic clinics.
[91] J. Bartfield,et al. Neonatal fever: utility of the Rochester criteria in determining low risk for serious bacterial infections. , 1997, The American journal of emergency medicine.
[92] D. Korones,et al. Febrile infants at low risk for serious bacterial infection--an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. , 1994, Pediatrics.
[93] Peiris Js,et al. Outpatient management of fever in selected infants. , 1994 .
[94] Louis M. Bell,et al. Outpatient management without antibiotics of fever in selected infants. , 1993, The New England journal of medicine.
[95] W. Bonadio,et al. Efficacy of a Protocol to Distinguish Risk of Serious Bacterial Infection in the Outpatient Evaluation of Febrile Young Infants , 1993, Clinical pediatrics.
[96] D. Schriger,et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. , 1993, Annals of emergency medicine.
[97] K. Powell. Evaluation and management of febrile infants younger than 60 days of age , 1990, The Pediatric infectious disease journal.
[98] R. Dagan,et al. Ambulatory care of febrile infants younger than 2 months of age classified as being at low risk for having serious bacterial infections. , 1988, The Journal of pediatrics.
[99] C B Hall,et al. Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. , 1985, The Journal of pediatrics.
[100] N. Team. Fever in under 5s: assessment and initial management , 2019 .
[101] O. Megged. Bacteremic vs nonbacteremic urinary tract infection in children☆,☆☆ , 2017, The American journal of emergency medicine.
[102] J. Bouyer,et al. Use of Procalcitonin Assays to Predict Serious Bacterial Infection in Young Febrile Infants. , 2016, JAMA pediatrics.
[103] S. Schrag,et al. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[104] Acepclinicalpoliciescommittee. Clinical policy for children younger than three years presenting to the emergency department with fever. , 2003, Annals of emergency medicine.
[105] J. Peiris,et al. Outpatient management of fever in selected infants. , 1994, New England Journal of Medicine.
[106] G. Fleisher,et al. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone. , 1992, The Journal of pediatrics.
[107] A. MacGowan,et al. Listeriosis--the therapeutic options. , 1990, The Journal of antimicrobial chemotherapy.